What is a stock summary page? Click here for an overview.
Business Description
PeptiDream Inc
ISIN : JP3836750004
Description
PeptiDream Inc is a biopharmaceutical company, engaged in the research and development of new pharmaceutical candidates. It discovers constrained peptides, small molecules, and peptide-drug conjugate therapeutics using its Peptide Discovery Platform System. The company aspires to be a leader in drug discovery and development to address unmet medical needs and improve the quality of life of patients worldwide.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.45 | |||||
Equity-to-Asset | 0.61 | |||||
Debt-to-Equity | 0.35 | |||||
Debt-to-EBITDA | 0.83 | |||||
Interest Coverage | 32.04 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 7.13 | |||||
Beneish M-Score | -2.9 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 70.5 | |||||
3-Year EBITDA Growth Rate | 75.1 | |||||
3-Year EPS without NRI Growth Rate | 80.1 | |||||
3-Year FCF Growth Rate | 58.5 | |||||
3-Year Book Growth Rate | 30.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 6.08 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 5.73 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 100 | |||||
9-Day RSI | 99.99 | |||||
14-Day RSI | 99.57 | |||||
6-1 Month Momentum % | 5 | |||||
12-1 Month Momentum % | 87.89 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.11 | |||||
Quick Ratio | 2.96 | |||||
Cash Ratio | 2.61 | |||||
Days Inventory | 80.24 | |||||
Days Sales Outstanding | 81.99 | |||||
Days Payable | 110.42 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.1 | |||||
Shareholder Yield % | -0.17 |
Profitability Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 73.92 | |||||
Operating Margin % | 45.23 | |||||
Net Margin % | 32.17 | |||||
FCF Margin % | 50.8 | |||||
ROE % | 29.52 | |||||
ROA % | 17.82 | |||||
ROIC % | 34.1 | |||||
3-Year ROIIC % | 47.29 | |||||
ROC (Joel Greenblatt) % | 98.22 | |||||
ROCE % | 30.87 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 18.48 | |||||
Forward PE Ratio | 25.07 | |||||
PE Ratio without NRI | 18.48 | |||||
Shiller PE Ratio | 62.91 | |||||
Price-to-Owner-Earnings | 16.8 | |||||
PEG Ratio | 0.54 | |||||
PS Ratio | 5.94 | |||||
PB Ratio | 4.88 | |||||
Price-to-Tangible-Book | 5.99 | |||||
Price-to-Free-Cash-Flow | 12.83 | |||||
Price-to-Operating-Cash-Flow | 11.64 | |||||
EV-to-EBIT | 11.54 | |||||
EV-to-Forward-EBIT | 14.61 | |||||
EV-to-EBITDA | 10.45 | |||||
EV-to-Forward-EBITDA | 12.72 | |||||
EV-to-Revenue | 5.33 | |||||
EV-to-Forward-Revenue | 6.48 | |||||
EV-to-FCF | 11.5 | |||||
Price-to-GF-Value | 0.68 | |||||
Price-to-Projected-FCF | 2.06 | |||||
Price-to-DCF (Earnings Based) | 0.58 | |||||
Price-to-DCF (FCF Based) | 0.36 | |||||
Price-to-Median-PS-Value | 0.08 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.74 | |||||
Price-to-Graham-Number | 2.22 | |||||
Price-to-Net-Current-Asset-Value | 13.03 | |||||
Price-to-Net-Cash | 22.88 | |||||
Earnings Yield (Greenblatt) % | 8.67 | |||||
FCF Yield % | 7.8 | |||||
Forward Rate of Return (Yacktman) % | 22.33 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:PPTDF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
PeptiDream Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 301.578 | ||
EPS (TTM) ($) | 0.726 | ||
Beta | 0.74 | ||
3-Year Sharpe Ratio | 0.26 | ||
3-Year Sortino Ratio | 0.38 | ||
Volatility % | 41.2 | ||
14-Day RSI | 99.57 | ||
14-Day ATR ($) | 0.000527 | ||
20-Day SMA ($) | 17.85 | ||
12-1 Month Momentum % | 87.89 | ||
52-Week Range ($) | 9.5 - 18 | ||
Shares Outstanding (Mil) | 129.61 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
PeptiDream Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
PeptiDream Inc Stock Events
Event | Date | Price ($) | ||
---|---|---|---|---|
No Event Data |
PeptiDream Inc Frequently Asked Questions
What is PeptiDream Inc(PPTDF)'s stock price today?
The current price of PPTDF is $17.85. The 52 week high of PPTDF is $18.00 and 52 week low is $9.50.
When is next earnings date of PeptiDream Inc(PPTDF)?
The next earnings date of PeptiDream Inc(PPTDF) is .
Does PeptiDream Inc(PPTDF) pay dividends? If so, how much?
PeptiDream Inc(PPTDF) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |